Pharmaceutical - Asia-Pacific, Metabolics

Filter

Current filters:

Asia-PacificMetabolics

Popular Filters

Arena Pharma links with Ildong for Belviq marketing in South Korea

08-11-2012

USA-based Arena Pharmaceuticals (Nasdaq: ARNA) has entered into a marketing and supply agreement with…

Arena PharmaceuticalsAsia-PacificBelviqIldong PharmaLicensingMarkets & MarketingMetabolicsPharmaceutical

AstraZeneca drops early-stage obesity drug; Roche loses out on Indian Tarceva dispute

10-09-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has told its development partner Palatin Technologies…

Asia-PacificAstraZenecaCiplaErlocipGenericsMetabolicsOncologyPalatin TechnologiesPatentsPharmaceuticalResearchRocheTarceva

CASiGEN Pharma created in Hong Kong to bring new potential diabetes treatments to global market

21-05-2012

USA-based Ventac Partners and the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences…

Asia-PacificCASiGEN PharmaDiabetesMarkets & MarketingMetabolicsPharmaceuticalResearch

Back to top